Matches in Wikidata for { <http://www.wikidata.org/entity/Q61965746> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- Q61965746 description "clinical trial" @default.
- Q61965746 description "ensayo clínico" @default.
- Q61965746 description "ensayu clínicu" @default.
- Q61965746 description "klinisch onderzoek" @default.
- Q61965746 description "клінічне випробування" @default.
- Q61965746 description "临床试验" @default.
- Q61965746 name "Efficacy of a 12-Week Regimen of Telaprevir, Pegylated Interferon, and Ribavirin in Treatment-Naive and Prior Relapser Subjects With Interleukin28B (IL28B) CC Genotype" @default.
- Q61965746 type Item @default.
- Q61965746 label "Efficacy of a 12-Week Regimen of Telaprevir, Pegylated Interferon, and Ribavirin in Treatment-Naive and Prior Relapser Subjects With Interleukin28B (IL28B) CC Genotype" @default.
- Q61965746 prefLabel "Efficacy of a 12-Week Regimen of Telaprevir, Pegylated Interferon, and Ribavirin in Treatment-Naive and Prior Relapser Subjects With Interleukin28B (IL28B) CC Genotype" @default.
- Q61965746 P1050 Q61965746-67BEBC0E-924B-47F3-9415-2CF2A84C2AE5 @default.
- Q61965746 P1050 Q61965746-E54FC110-C9C2-419D-BBDD-D1E0A1D9C774 @default.
- Q61965746 P1132 Q61965746-DED77C40-5A89-419B-84D5-297933AF991A @default.
- Q61965746 P1476 Q61965746-D054D65D-9CA2-46B5-953F-12FF00662E56 @default.
- Q61965746 P17 Q61965746-1A1AA5C3-B235-477A-868C-0CD4A7B4E649 @default.
- Q61965746 P17 Q61965746-2CDA7C05-17C4-4920-AF27-E4D268293296 @default.
- Q61965746 P17 Q61965746-5A1EEDBC-ED56-467E-87E6-234AEE83057D @default.
- Q61965746 P17 Q61965746-74B70789-D6DA-46D9-8119-EC22A045C63C @default.
- Q61965746 P17 Q61965746-E254E9C6-988F-476C-9EDC-E57C08A2ECC3 @default.
- Q61965746 P17 Q61965746-EBCC8073-D84C-48B5-9806-804B657418B0 @default.
- Q61965746 P1813 Q61965746-CD6492BA-EFF7-46D3-94F8-9C69880060AE @default.
- Q61965746 P2899 Q61965746-FF64B3C3-E642-488D-9D37-701789C69365 @default.
- Q61965746 P3098 Q61965746-7A77B197-9057-4F27-B87F-B50A141576FB @default.
- Q61965746 P31 Q61965746-8A3E3238-431B-4757-AC65-9A7831792A09 @default.
- Q61965746 P4135 Q61965746-C9D71500-B489-4D5F-8A32-A36347F8EDED @default.
- Q61965746 P4844 Q61965746-5793C8E4-6A99-4294-BD5D-9224BE5C9D7F @default.
- Q61965746 P4844 Q61965746-BBB93003-90EB-43F3-9AB3-B84D148C5E4A @default.
- Q61965746 P4844 Q61965746-C081ABFE-9D07-4BFC-AE64-3D9AB7ECF565 @default.
- Q61965746 P580 Q61965746-BE64D3E2-323A-4930-ABC2-DDF2AA0E785C @default.
- Q61965746 P582 Q61965746-E6221048-A74E-47CD-96F4-3C68897F54CA @default.
- Q61965746 P6099 Q61965746-47DBBB68-0127-4069-8BC4-28435E45F6B5 @default.
- Q61965746 P8005 Q61965746-43E43745-1044-4A9A-B7CA-8187A66CD77F @default.
- Q61965746 P8363 Q61965746-367F5D47-762E-4226-877D-F51B725F3C15 @default.
- Q61965746 P1050 Q131742 @default.
- Q61965746 P1050 Q154869 @default.
- Q61965746 P1132 "+239" @default.
- Q61965746 P1476 "A Phase 3b Study of 2 Treatment Durations of Telaprevir, Peg-IFN (Pegasys®), and Ribavirin (Copegus®) in Treatment-Naive and Prior Relapser Subjects With Genotype 1 Chronic Hepatitis C and IL28B CC Genotype" @default.
- Q61965746 P17 Q16 @default.
- Q61965746 P17 Q183 @default.
- Q61965746 P17 Q30 @default.
- Q61965746 P17 Q36 @default.
- Q61965746 P17 Q40 @default.
- Q61965746 P17 Q801 @default.
- Q61965746 P1813 "CONCISE" @default.
- Q61965746 P2899 "+18" @default.
- Q61965746 P3098 "NCT01459913" @default.
- Q61965746 P31 Q30612 @default.
- Q61965746 P4135 "+70" @default.
- Q61965746 P4844 Q20817235 @default.
- Q61965746 P4844 Q420056 @default.
- Q61965746 P4844 Q421862 @default.
- Q61965746 P580 "2011-11-01T00:00:00Z" @default.
- Q61965746 P582 "2014-01-01T00:00:00Z" @default.
- Q61965746 P6099 Q42824827 @default.
- Q61965746 P8005 Q76649944 @default.
- Q61965746 P8363 Q78089383 @default.